<DOC>
	<DOCNO>NCT01568086</DOCNO>
	<brief_summary>This phase Ib follow-up study evaluate long-term safety tolerability immunization AFFITOPE AD03 apply AFFiRiS 005A .</brief_summary>
	<brief_title>Follow-up Study Evaluate Long-term Safety Tolerability Immunization With AD03 Applied During AFF005A</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Written inform consent sign dated patient caregiver . Patients participate AFFiRiS 005A receive â‰¥1 vaccination AFFITOPE AD03 Availability partner/caregiver know patient able accompany patient visit available telephone phone call Patients received vaccination AFFITOPE AD03 History questionable compliance visit schedule ; patient expect complete clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>